A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study To Assess The Efficacy And Safety Of Verekitug (Upb-101) In Participants With Chronic Rhinosinusitis With Nasal Polyps On A Background Of Nasal Corticosteroids (Vibrant)
Posted Date: Apr 22, 2024
- Investigator: Ahmad Sedaghat
- Specialties:
- Type of Study: Drug
The main purpose of this study is to learn more about verekitug (UPB-101) by comparing it with placebo. Another purpose of this study is to learn the effect of verekitug (UPB-101) on lung function in participants who also have asthma, in addition to their CRSwNP.
Criteria:
Null
Keywords:
Chronic Rhinosinusitis, Nasal Polyps
For More Information:
Rebecca Reinert
513-558-1719
gibsonrk@uc.edu